hims semaglutide dosing News 🚨 by $HIMS & Hers just announced that (the active ingredient in Ozempic/Wegovy) has become significantly more affordable in Canada. Eligible patients can now access both generic and branded Hims & Hers can't sell

Patient 1 The patient is a 36-year-old college-educated woman with a psychiatric history of major depressive disorder, generalized anxiety disorder, and binge-eating disorder and a medical history of asthma, eczema, and seasonal allergies

With our passion for helping patients look and feel their best, who better to bring you the cutting edge in medical weight loss

Lillys CEO Dave Ricks warned that the growth of compounding could create a backdoor generic world. This article is exclusive to STAT+ subscribers Unlock this article plus daily coverage and analysis of the pharma industry by subscribing to STAT+

A review of serious adverse events linked with glp-1 agonists in type 2 diabetes mellitus and obesity treatment

The regulatory status of the intended peptide therapy is extremely important to know because there are country-wise and regional restrictions on the supplements